$473 Million is the total value of Foresite Capital Management II, LLC's 7 reported holdings in Q3 2019. The portfolio turnover from Q2 2019 to Q3 2019 was 28.6% .
| Value | Shares | ↓ Weighting | ||||||
|---|---|---|---|---|---|---|---|---|
| TXG | New | 10x Genomics, Inc. | $344,598,000 | – | 6,837,253 | +100.0% | 72.85% | – |
| AIMT | Sell | Aimmune Therapeutics, Inc. | $54,559,000 | -3.9% | 2,605,499 | -4.4% | 11.53% | -63.9% |
| AERI | Aerie Pharmaceuticals, Inc. | $32,150,000 | -35.0% | 1,672,714 | 0.0% | 6.80% | -75.5% | |
| INSM | Sell | Insmed Incorporated | $16,141,000 | -34.0% | 915,016 | -4.2% | 3.41% | -75.2% |
| EPZM | Epizyme, Inc. | $15,353,000 | -17.8% | 1,488,444 | 0.0% | 3.25% | -69.1% | |
| XLRN | Acceleron Pharma Inc. | $7,452,000 | -3.8% | 188,602 | 0.0% | 1.58% | -63.8% | |
| ALDR | Sell | Alder BioPharmaceuticals, Inc. | $2,769,000 | -85.2% | 146,800 | -90.7% | 0.58% | -94.4% |
| TWST | Exit | Twist Bioscience Corporation | $0 | – | -72,849 | -100.0% | -1.19% | – |
Original filings
The following EDGAR filing(s) were analyzed to create this report:
- View 13F-HR filed 2019-11-13
Top long-term holdings
| Name | Quarters owned | Latest quarter owned | Max weighting |
|---|---|---|---|
| Epizyme, Inc. | 29 | Q4 2021 | 11.9% |
| Acceleron Pharma Inc. | 24 | Q3 2021 | 4.8% |
| Aerie Pharmaceuticals, Inc. | 22 | Q1 2020 | 40.3% |
| 10x Genomics, Inc. | 17 | Q3 2023 | 100.0% |
| Aimmune Therapeutics, Inc. | 17 | Q3 2019 | 41.0% |
| Alder BioPharmaceuticals, Inc. | 16 | Q3 2019 | 12.6% |
| Zafgen, Inc. | 12 | Q3 2017 | 33.5% |
| BioDelivery Sciences International, Inc. | 12 | Q1 2019 | 3.2% |
| Insmed Incorporated | 11 | Q1 2020 | 13.8% |
| Adaptimmune Therapeutics PLC | 9 | Q4 2018 | 11.3% |
View Foresite Capital Management II, LLC's complete holdings history.
Latest filings
| Type | Filed |
|---|---|
| 13F-HR | 2023-11-13 |
| 13F-HR | 2023-08-11 |
| 13F-HR | 2023-05-12 |
| 13F-HR | 2023-02-13 |
| 13F-HR | 2022-11-14 |
| 13F-HR | 2022-08-12 |
| 13F-HR | 2022-05-13 |
| 13F-HR | 2022-02-11 |
| 13F-HR | 2021-11-12 |
| 13F-HR | 2021-08-16 |
View Foresite Capital Management II, LLC's complete filings history.
All filings
- Holdings (13F-HR)
- Significant ownership (13-D/G)
- Insider transactions (4, 5, 6)
- Events (8-K)
- Shareholder votes (proxy)
View complete filings history.